Emcure Pharmaceuticals Signs Agreement with Gilead for the Manufacture and Global Supply of Lenacapavir

03.10.2024

Emcure Pharmaceuticals Announces Strong Q1FY25 Results with 17% Revenue Growth and 16% EBITDA Growth

13.08.2024

Emcure Pharmaceuticals strengthens its commitment to energy conservation, signs PPA with Sunsure Energy for solar power.

25.07.2024